Global tissue engineered medical devices market forecast and opportunities, 2020

Loading...

PPT – Global tissue engineered medical devices market forecast and opportunities, 2020 PowerPoint presentation | free to download - id: 7eb8d0-OTRlZ



Loading


The Adobe Flash plugin is needed to view this content

Get the plugin now

View by Category
About This Presentation
Title:

Global tissue engineered medical devices market forecast and opportunities, 2020

Description:

Pharmaion offers latest market research report for "Global tissue engineered medical devices" that show the global tissue engineered medical devices market is anticipated to surpass US$ 26 billion by 2020. – PowerPoint PPT presentation

Number of Views:4

less

Write a Comment
User Comments (0)
Transcript and Presenter's Notes

Title: Global tissue engineered medical devices market forecast and opportunities, 2020


1
Gl o ba l T i s s ue E n g i n eered Medi c a l D
evi ces Ma rket Fo rec as t Oppo rtun i t i es
, 2020
P h a r m a H e a l t h c a r e C o n
s u l t a n t s
2
I n d u s t r y B r i e f Global tissue
engineered medical devices market is anticipated
to cross US 26 billion by 2020 Increasing aging
population, rising number of diabetic patients
and various ongoing innovations to drive the
global tissue engineered medical devices
market According to recently published Pharmaion
report, Global Tissue Engineered Medical Devices
Market Forecast And opportunities, 2020, global
tissue engineered medical devices market is
anticipated to cross US 26 billion by 2020. A
wide array of factors that are expected to
positively influence the global tissue
engineered medical devices market during forecast
period include increasing aging population,
ongoing technological advancements and growing
consumer awareness. Moreover, as compared to
artificial implants, tissue engineered implants
offer better biocompatibility, thereby minimizing
the probability of rejection of implant from the
body. Global tissue engineered medical devices
market is also driven by the increasing
prevalence diabetes and associated diseases
across the globe. Diabetes carries a high risk of
cardiovascular diseases and neuropathy.
Neuropathy is among the root causes of foot
amputations and ulcers in the diabetic patient,
and treatment process in this case requires skin
substitutes. Rising prevalence of diabetes and
resulting increase in foot ulcers is expected to
be one of the major factors responsible for the
rapid growth of skin substitutes during the
forecast period. New product launches by
existing market players as well as new entrants
is expected to boost the global tissue
engineered medical devices market during forecast
period. North America dominated the global tissue
engineered medical devices market in 2014, and
is anticipated to continue its dominance through
2020 as the percentage of geriatric population
is very high in this region. Moreover, the
economic stability of the region also helps
patients to undergo expensive treatment options.
Global tissue engineered medical devices market
will continue to exhibit growth during the next
five years. Growing adoption of nanotechnology
and 3D Bioprinting, rising application of
engineered protein, and escalating applications
of stem cells are among the major factors driving
global tissue engineered medical devices market.
The demand of skin substitutes is increasing at a
significant pace on account of rising neuropathy
cases among diabetics and improving efficacy of
skin substitute products. said Mr. Karan Chechi,
Research Director with Pharmaion, a research
based global pharmaceutical and healthcare
consulting firm.
2
3
T a b l e o f C o n t e n t s
S. No. Contents Contents Contents Contents
1. Research Methodology Research Methodology Research Methodology Research Methodology
2. Analyst View Analyst View Analyst View Analyst View
3. Tissue Engineering Overview Tissue Engineering Overview Tissue Engineering Overview Tissue Engineering Overview
4. Global Tissue Engineered Medical Devices Market Outlook Global Tissue Engineered Medical Devices Market Outlook Global Tissue Engineered Medical Devices Market Outlook Global Tissue Engineered Medical Devices Market Outlook
4.1. Market Size Forecast Market Size Forecast Market Size Forecast
4.1.1. By Value By Value
4.1.2. By Volume By Volume
4.2. Market Share Forecast Market Share Forecast Market Share Forecast
4.2.1. By Application By Application
4.2.2. By Source By Source
4.2.3. By Region By Region
4.2.4. By Company By Company
4.3. Quality Control Policies Quality Control Policies Quality Control Policies
5. Global Tissue Engineered Medical Devices Segmental Market Outlook Global Tissue Engineered Medical Devices Segmental Market Outlook Global Tissue Engineered Medical Devices Segmental Market Outlook Global Tissue Engineered Medical Devices Segmental Market Outlook
5.1. Global Orthopedic Tissue Engineered Medical Devices Market Outlook Global Orthopedic Tissue Engineered Medical Devices Market Outlook Global Orthopedic Tissue Engineered Medical Devices Market Outlook
5.1.1. Market Size Forecast Market Size Forecast
5.1.1.1. By Value
5.1.1.2. By Volume
5.1.2. Market Share Forecast Market Share Forecast
5.1.2.1. By Product Type
5.1.2.2. By Region
5.1.2.3. By Company
5.2. Global Cardiac Tissue Engineered Medical Devices Market Outlook Global Cardiac Tissue Engineered Medical Devices Market Outlook Global Cardiac Tissue Engineered Medical Devices Market Outlook
4
T a b l e o f C o n t e n t s
S. No. Contents Contents Contents Contents
5.2.1. Market Share Forecast Market Share Forecast
5.2.1.1. By Value
5.2.1.2. By Volume
5.2.2. Market Share Forecast Market Share Forecast
5.2.2.1. By Product Type
5.2.2.2. By Region
5.2.2.3. By Company
5.3. Global Dental Tissue Engineered Medical Devices Market Outlook Global Dental Tissue Engineered Medical Devices Market Outlook Global Dental Tissue Engineered Medical Devices Market Outlook
5.3.1. Market Size Forecast Market Size Forecast
5.3.1.1. By Value
5.3.1.2. By Volume
5.3.2. Market Share Forecast Market Share Forecast
5.3.2.1. By Product Type
5.3.2.2. By Region
5.3.2.3. By Company
5.4. Global Skin Substitutes Engineered Medical Devices Market Outlook Global Skin Substitutes Engineered Medical Devices Market Outlook Global Skin Substitutes Engineered Medical Devices Market Outlook
5.4.1. Market Size Forecast Market Size Forecast
5.4.1.1. By Value
5.4.1.2. By Volume
5.4.2. Market Share Forecast Market Share Forecast
5.4.2.1. By Application
5.4.2.2. By Region
5.4.2.3. By Company
5
T a b l e o f C o n t e n t s
S. No. Contents Contents Contents Contents
6. Global Tissue Engineered Medical Devices Regional Market Outlook Global Tissue Engineered Medical Devices Regional Market Outlook Global Tissue Engineered Medical Devices Regional Market Outlook Global Tissue Engineered Medical Devices Regional Market Outlook
6.1. North America Tissue Engineered Medical Devices Market Outlook North America Tissue Engineered Medical Devices Market Outlook North America Tissue Engineered Medical Devices Market Outlook
6.1.1. Market Size Forecast Market Size Forecast
6.1.1.1. By Value
6.1.2. Market Share Forecast Market Share Forecast
6.1.2.1. By Country
6.1.2.2. By Application
6.2. Europe Tissue Engineered Medical Devices Market Outlook Europe Tissue Engineered Medical Devices Market Outlook Europe Tissue Engineered Medical Devices Market Outlook
6.2.1. Market Size Forecast Market Size Forecast
6.2.1.1. By Value
6.2.2. Market Share Forecast Market Share Forecast
6.2.2.1. By Country
6.2.2.2. By Application
6.3. South America Tissue Engineered Medical Devices Market Outlook South America Tissue Engineered Medical Devices Market Outlook South America Tissue Engineered Medical Devices Market Outlook
6.3.1. Market Size Forecast Market Size Forecast
6.3.1.1. By Value
6.3.2. Market Share Forecast Market Share Forecast
6.3.2.1. By Country
6.3.2.2. By Application
6
T a b l e o f C o n t e n t s
S. No. Contents Contents Contents Contents
6.4. Asia-Pacific Tissue Engineered Medical Devices Market Outlook Asia-Pacific Tissue Engineered Medical Devices Market Outlook Asia-Pacific Tissue Engineered Medical Devices Market Outlook
6.4.1. Market Size Forecast Market Size Forecast
6.4.1.1. By Value
6.4.2. Market Share Forecast Market Share Forecast
6.4.2.1. By Country
6.4.2.2. By Application
6.5. Middle East Africa Tissue Engineered Medical Devices Market Outlook Middle East Africa Tissue Engineered Medical Devices Market Outlook Middle East Africa Tissue Engineered Medical Devices Market Outlook
6.5.1. Market Size Forecast Market Size Forecast
6.5.1.1. By Value
6.5.2. Market Share Forecast Market Share Forecast
6.5.2.1. By Country
6.5.2.2. By Application
7. Market Dynamics Market Dynamics Market Dynamics Market Dynamics
7.1. Drivers Drivers Drivers
7.2. Challenges Challenges Challenges
8. Market Trends Developments Market Trends Developments Market Trends Developments Market Trends Developments
8.1. Nanotechnology in Tissue Engineering Nanotechnology in Tissue Engineering Nanotechnology in Tissue Engineering
8.2. 3D Bioprinting Advancing the Tissue Engineering 3D Bioprinting Advancing the Tissue Engineering 3D Bioprinting Advancing the Tissue Engineering
8.3. Bone Tissue Engineering Witnessing Continuous Innovation Bone Tissue Engineering Witnessing Continuous Innovation Bone Tissue Engineering Witnessing Continuous Innovation
8.4. Increasing Use of Tissue Engineered for Chronic Wound Healing Increasing Use of Tissue Engineered for Chronic Wound Healing Increasing Use of Tissue Engineered for Chronic Wound Healing
8.5. Rising Application of Engineered Protein in Tissue Engineering Rising Application of Engineered Protein in Tissue Engineering Rising Application of Engineered Protein in Tissue Engineering
7
T a b l e o f C o n t e n t s
S. No. Contents Contents Contents Contents
8.6. Tissue Engineering and Biomaterials will Revolutionize Plastic Surgery Industry Tissue Engineering and Biomaterials will Revolutionize Plastic Surgery Industry Tissue Engineering and Biomaterials will Revolutionize Plastic Surgery Industry
8.7. Tissue Engineering Future of Ophthalmology Tissue Engineering Future of Ophthalmology Tissue Engineering Future of Ophthalmology
8.8. Escalating Use of Stem Cells in Tissue Engineering Research Escalating Use of Stem Cells in Tissue Engineering Research Escalating Use of Stem Cells in Tissue Engineering Research
9. Competitive Landscape Competitive Landscape Competitive Landscape Competitive Landscape
9.1. Competition Benchmarking Competition Benchmarking
9.2. Company Profiles Company Profiles
9.2.1. Medtronic plc
9.2.2. Stryker Corporation
9.2.3. Zimmer Biomet
9.2.4. DePuy Synthes
9.2.5. Edwards Lifesciences Corporation
9.2.6. Smith Nephew
9.2.7. Geistlich Pharma AG
9.2.8. Organogenesis Inc.
9.2.9. Institut Straumann AG
9.2.10. CryoLife, Inc.
9.2.11. Dentsply International
9.2.12. Integra LifeSciences Corporation
9.2.13. MiMedx Group, Inc.
9.2.14. St. Jude Medical, Inc.
9.2.15. B. Braun Melsungen AG
9.2.16. Wright Medical Technology, Inc.
8
T a b l e o f C o n t e n t s
S. No. Contents Contents Contents Contents
9.2.17. ACE Surgical Supply Company, Inc.
9.2.18. BioHorizons IPH, Inc.
9.2.19. Botiss Biomaterials GmbH
9.2.20. Cytograft Tissue Engineering
9.2.21. Mölnlycke Health Care
9.2.22. TEI Biosciences
10. Strategic Recommendations Strategic Recommendations Strategic Recommendations Strategic Recommendations
11. About Us Disclaimer About Us Disclaimer About Us Disclaimer About Us Disclaimer
9
R e s e a r c h M e t h o d o l o g y
Baseline Methodology
For the study, Pharmaion has gathered information
through primary research with respondents in
tissue engineered medical devices market across
the globe, followed by external validation of the
information by interviewing the users. We also
gathered insights through an exhaustive search of
credible paid databases and our internal
database. Our team of analysts has prudently
evaluated all the collected information and
presented the same in chronological order to
depict a meaningful and clear picture of tissue
engineered medical devices in all the
regions across the world. While compiling the
data, we have also validated all the collected
information from multiple sources and data
warehouses, in order to present the most accurate
and precise information of the concerned
industry. The information has then been verified
through primary research surveys with competitors
to arrive at logical figures.
Companies Interviewed
SRI Research, Medtronic Inc., DePuy Synthes, Cryolife, Inc., Wright Medical Technology, Smith Nephew, Ferentis
Sources Company Websites, Company Annual
Reports, Government Database (American Academy of
Orthopedic Surgeons, Centers for Disease
Control and Prevention, CORDIS, etc.), WHO
Reports
10
S a m p l e D a t a - S n a p s h o t
Global Tissue Engineered Medical Devices Market
Share, By Source, By Value, 2010-2020F
United States Prevalence of Cardiovascular
Disease in Adults above
United States Percentage Breakdown of Deaths due
to Cardiovascular Disease, 2011
60.00 60.10 60.20 60.30 60.40 60.50
60.60 60.70 60.80 60.90 61.00 20
years of Age, By Age, By Sex, 2015
( of total population)
Coronary Heart Disease, 10.00
Others, 10.00
9
7
35.00 35.10 35.20 35.30 35.40 35.50
35.60 35.70 35.80 35.90 36.00
Diseases of Arteries, 10.00
5
4
3
3
Stroke, 10.00
2
1
Heart Failure, 10.00
2010 2011 2012 2013 2014 2015E
2016F 2017F 2018F 2019F 2020F Synthetic
Biomaterials Natural Biomaterials Global Tissue
Engineered Medical Devices Market Share, By
Company, By Value, 2014 2020F
High Blood Pressure, 10.00
20-39
40-59
60-79
80
Men
Women
North America Tissue Engineered Medical
United States Demand for Kidney Donor, 1990
2012 Kidney Transp
Devices Market Size, By Value (USD
Medtronic plc, 15.00 Stryker Corporati on,
15.00
12
Billion), 2010-2020F
11
Medtronic plc, 10.00
Others, 25.00
10
Others, 10.00
9
8
7
5
4
3
2
10000
1
Edwards Lifesciences 2014 Corporation, 10.00
Stryker Corporation, 10.00
lant Opera tions
Edwards
Lifescienc 2020F es Corporati
1000
Zimmer 12,000 16,485
Zimmer Biomet, 10.00
on,
Biomet, 15.00
Depuy
1990 2012 Global Tissue Engineered Medical
Devices Market Share, By Application, By Value,
Depuy Synthes, 10.00
15.00 Synthes, 15.00
2010-2020F
Global Tissue Engineered Medical Devices Market
Size, By Value (USD Billion), By Volume
55.80
55.90
56.00
55.60
55.70
55.40
55.50
55.20
55.30
55.00 55.10
(Million Units), 2010-2020F
25
23
21
19
17
14.90 6.90
15.00 7.00
14.60
14.70
14.80
14.30
14.40
14.50
14.10
14.20
15
12
14.00
11
11
9
9
8
10 6.00 6.10 6.20 6.30 6.40 6.50 6.60 6.70 6.80
3.00 3.10 3.20 3.30 3.40 3.50 3.60 3.70 3.80 3.90 4.00

7
7
5
5
4
3
3
2
1
10
17.00 17.10 17.20 17.30
17.40 17.50 17.60 17.70
17.80 17.90 18.00
2010 2011 2012 2013 2014 Value (USD Billion)
2015E2016F2017F2018F2019F2020F Volume (Million
Units)
2010
2011 2012 2013 2014 2015E 2016F 2017F 2018F 2019F
2020F Others Skin Substitute Dental
Pharmaion
11
R e p o r t O r d e r i n g
Report Name Global Tissue Engineered Medical
Devices Market Forecast and Opportunities, 2020
Report Price
License Type Price
Single User License 4000
Single User License Print 4500
Enterprise License 8000
To View Sample OR Purchase Report
11
12
A b o u t U s D i s c l a i m e r About
Us Pharmaion is a research based management
consulting firm focused exclusively on Healthcare
Pharmaceutical industry. Pharmaions core
values are value, integrity and insight. Led by a
team of dynamic industry experts, Pharmaion
provides its customers with high value market
research and advisory services that helps them
identify new market opportunities, growth engines
and innovative ways to capture the market share.
As a result, Pharmaions clients lead rather than
follow market trends. Not bound by legacy,
Pharmaions cutting-edge research model leverages
its decades of research knowledge and an
increased use of technology as engines of
innovation to deliver unique research value.
Provided as an alternative to traditional market
research, Pharmaions reports do not just
deliver data and knowledge rather highlights the
insights in a more usable and interactive format
for its clients. Pharmaion is committed to
assisting customers worldwide with their unique
market research needs by providing them with
comprehensive, value-added solutions and
professional market intelligence services.
Pharmaion employs the industrys best-trained
industry Analysts and Consultants, which advises
and assists customers in meeting their full
service market research and consulting
requirements. Related Reports India Stem Cells
Market Forecast Opportunities, 2020 India
Infertility Treatment Market Forecast
Opportunities, 2020 Global Cervical Cancer
Vaccine Market Forecast Opportunities, 2020
Disclaimer The contents of this report are based
on information generally available to the public
from sources believed to be reliable. No
representation is made that it is timely,
accurate or complete. Pharmaion Consultants has
taken due care and caution in compilation of data
as this has been obtained from various sources
including which it considers reliable and first
hand. However, Pharmaion Consultants does not
guarantee the accuracy, adequacy or completeness
of any information and it is not responsible for
any errors or omissions or for the results
obtained from the use of such information and
especially states that it has no financial
liability whatsoever to the subscribers / users
of this report. The information herein, together
with all estimates and forecasts, can change
without notice. All the figures provided in this
document are indicative of relative market size
and are strictly for clients internal
consumption. Usage of the same for purpose other
than internal will require prior approval of
Pharmaion Consultants.
NORTH AMERICA Pharmaion Consultants LLC 708 3RD
Avenue, 6th Floor, New York, NY, United State,
10017 sales_at_pharmaion.com 1 646 360
1656 www.pharmaion.com
ASIA PACIFIC Pharmaion Consultants Pvt. Ltd. A
51, Sector 57, Noida, National Capital
Region, India - 201301 sales_at_pharmaion.com 91 -
120 - 452 3900 www.pharmaion.com
12